Fletcher SA - Search Results

1

The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years.

Fletcher SA, Cole AP, Lu C, Marchese M, Krimphove MJ, Friedlander DF, Mossanen M, Kilbridge KL, Kibel AS, Trinh QD. Fletcher SA, et al. Cancer. 2020 Feb 1;126(3):496-505. doi: 10.1002/cncr.32562. Epub 2019 Oct 18. Cancer. 2020. PMID: 31626340 Free article.

2

Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database.

Fletcher SA, Cronin AM, Zeidan AM, Odejide OO, Gore SD, Davidoff AJ, Steensma DP, Abel GA. Fletcher SA, et al. Cancer. 2016 Apr 15;122(8):1209-15. doi: 10.1002/cncr.29913. Epub 2016 Feb 23. Cancer. 2016. PMID: 26914833 Free article.

3

Immortal-time bias: a crucial yet overlooked confounder in urological research.

Fletcher SA, Gild P, Trinh QD. Fletcher SA, et al. BJU Int. 2017 Oct;120(4):455. doi: 10.1111/bju.13966. BJU Int. 2017. PMID: 29206353 No abstract available.

4

Evaluation of magnetic resonance imaging and targeted biopsy: The difficulty of finding the right reference standard.

Berg S, Fletcher SA, Cole AP, Trinh QD. Berg S, et al. Among authors: fletcher sa. Cancer. 2018 Mar 15;124(6):1299-1300. doi: 10.1002/cncr.31201. Epub 2017 Dec 19. Cancer. 2018. PMID: 29266175 Free article. No abstract available.

5

The new frontier of prostate biopsy: determining the role of image-guidance in moving the needle.

Fletcher SA, Berg S, Trinh QD. Fletcher SA, et al. BJU Int. 2018 Jan;121(1):4-5. doi: 10.1111/bju.14052. BJU Int. 2018. PMID: 29314538 No abstract available.

6

Adoption of robotic surgery: driven by market competition or a desire to improve patient care?

Fletcher SA, Cole AP, Berg S, Pucheril D, Trinh QD. Fletcher SA, et al. Lancet Oncol. 2018 Feb;19(2):e66. doi: 10.1016/S1470-2045(18)30021-4. Lancet Oncol. 2018. PMID: 29413467 No abstract available.

7

The effect of treatment at minority-serving hospitals on outcomes for bladder cancer.

Fletcher SA, Gild P, Cole AP, Vetterlein MW, Kibel AS, Choueiri TK, Sonpavde GP, Preston MA, Pucheril D, Menon M, Sun M, Lipsitz SR, Trinh QD. Fletcher SA, et al. Urol Oncol. 2018 May;36(5):238.e7-238.e17. doi: 10.1016/j.urolonc.2018.01.010. Epub 2018 Feb 15. Urol Oncol. 2018. PMID: 29454591

8

Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy era.

Fletcher SA, Harmouch SS, Krimphove MJ, Cole AP, Berg S, Gild P, Preston MA, Sonpavde GP, Kibel AS, Sun M, Choueiri TK, Trinh QD. Fletcher SA, et al. World J Urol. 2018 Nov;36(11):1767-1774. doi: 10.1007/s00345-018-2371-y. Epub 2018 Jun 14. World J Urol. 2018. PMID: 29948050

9

Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer.

Krimphove MJ, Cole AP, Fletcher SA, Harmouch SS, Berg S, Lipsitz SR, Sun M, Nabi J, Nguyen PL, Hu JC, Kibel AS, Choueiri TK, Kluth LA, Trinh QD. Krimphove MJ, et al. Among authors: fletcher sa. Prostate Cancer Prostatic Dis. 2019 Mar;22(1):125-136. doi: 10.1038/s41391-018-0083-4. Epub 2018 Aug 31. Prostate Cancer Prostatic Dis. 2019. PMID: 30171227

10

Investigating the effect of treatment at high-volume hospitals on overall survival following cytoreductive nephrectomy.

Berg S, Cole AP, Fletcher SA, Pucheril D, Nabi J, Lipsitz SR, Chang SL, Sun M, Noldus J, Harshman LC, Choueiri TK, Trinh QD. Berg S, et al. Among authors: fletcher sa. Urol Oncol. 2018 Sep;36(9):400.e15-400.e22. doi: 10.1016/j.urolonc.2018.06.005. Urol Oncol. 2018. PMID: 30274640

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters